The burden of childhood tuberculosis and the accuracy of community-based surveillance data.

Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Health Sciences, University of Stellenbosch, Cape Town, South Africa.
The International Journal of Tuberculosis and Lung Disease (Impact Factor: 2.76). 03/2006; 10(3):259-63.
Source: PubMed

ABSTRACT Inadequate surveillance and diagnostic difficulties compromise the quality of epidemiological data on childhood tuberculosis (TB).
To document the incidence of childhood TB and to evaluate the accuracy of community-based surveillance data in a high-burden setting.
This prospective observational study was conducted from February 2003 to October 2004 at five primary health care clinics in Cape Town, South Africa. Comprehensive surveillance was done to ensure that all children <13 years of age treated for TB were included.
During the study period, 443 children (<13 years of age) received anti-tuberculosis treatment, of whom 389 (87.8%) were recorded in the TB treatment register. The TB incidence calculated from the TB treatment register was 441/100,000/year amongst children and 845/100,000/year amongst adults. Fifty-four children treated for TB were not recorded in the TB treatment register, including 21/28 (75%) children with severe disease.
Children <13 years of age contributed 13.7% of the total TB burden, but experienced more than half (52.2%) the TB incidence recorded in adults. Community-based surveillance data excluded the majority of children with severe disease. The accuracy of surveillance data is an important consideration when describing the epidemiology of childhood TB or measuring the success of public health interventions.


Available from: Ben Marais, Oct 02, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: Tuberculosis (TB) remains a major cause of morbidity and mortality, and Viet Nam ranks 12 among the 22 high-TB burden countries. This study analyses surveillance data of the National Tuberculosis Control Programme in Viet Nam for the six-year period 2007 to 2012. During the study period, 598 877 TB cases (all forms) were notified, and 313 225 (52.3%) were new smear-positive cases. The case notification rate of new smear-positive cases was decreased, from 65 per 100 000 population in 2007 to 57 per 100 000 population in 2012; this decrease was observed for males and females in all age groups except males aged 0-14 and females aged 15-24 years. The male-to-female ratio of new smear-positive TB cases increased from 2.85 in 2007 to 3.02 in 2012. The average annual cure rate of new smear-positive cases was 90.3%. The high male-to-female ratio for new smear-positive TB cases in this notification data was lower than that from the 2007 TB prevalence survey in Viet Nam, suggesting a lower case detection for males. The decrease in new smear-positive case notification rates may reflect a decline in TB incidence in Viet Nam as several programmatic improvements have been made, although further research is required to increase case detection among young males and children.
    01/2015; 6(1):7-14. DOI:10.5365/wpsar.2014.5.2.005
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Abstract. Background: Tuberculosis (TB) remains a major global health problem. The childhood tuberculosis has some unique features different which makes the diagnosis more complicated. Here we described the epidemiologic, clinical and microbiologic features of children with extra pulmonary and pulmonary TB. Methods: The data of the patients <17 years with active TB were collected and compared in pulmonary (PTB) and extrapulmonary TB (EXPTB) patients. Results: A total of 128 cases was included. Forty-two cases occurred in children were < 5 years of age; 41 cases between 6-10 years and 45 cases > 10 years. PTB was present in 75,0% of the cases, and EXPTB was present in 25% of cases. There was no significant difference between the EXPTB and PTB by means of distribution of age groups (p=0,201). The rate of patients free of constitutional symptoms were significantly higher in EXPTB compared to PTB(p=0,000). There was no significant difference between EXPTB and PTB by means of sources detection(p=0,069). Conclusion: TB is still a major public health problem. EXPTB has an insidious and silent onset without any constitutional symptoms, and both microbiological confirmation and the source by an adult are not frequently found. Moreover, detection of the adult source is mandatory for controlling the TB disease in children
    Mediterranean Journal of Hematology and Infectious Diseases 08/2014; 6(6). DOI:10.4084/MJHID.2014.058
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Document prepared for a 3-day International Workshop "Exploring Development of a birth cohort to understand and prevent diseases of children in the developing world" 1 Childhood mortality and respiratory disease Globally, respiratory illness is the major cause of childhood mortality. The World Health Organisation (WHO) estimates that approximately 10.6 million children under 5 years of age die each year; of which almost 2 million or 19% are due to acute respiratory infection (ARI), mainly pneumonia. 1 . In addition a further 10% of all childhood deaths are due to neonatal pneumonia or sepsis. The main burden of childhood respiratory disease and associated deaths occur in developing countries. 1-3 More than 90% of deaths from childhood ARI occur in developing countries, especially in Africa where almost half of pneumonia-associated deaths occur. 1,3 Other respiratory illnesses contributing to the global under-5 mortality include measles and HIV/AIDS, responsible for approximately 4% and 3% of deaths respectively. 1 A number of differences between developed and developing countries impact on the global burden of pediatric respiratory illness. Firstly, children account for a relatively higher proportion of the population in developing compared with developed countries. In 2005, children under 15 years of age comprised approximately 31% of the total population in developing countries, compared to 17% in developed nations. 4 Secondly the prevalence of some infectious agents may differ as a result of socioeconomic, medical or geographic factors. For example measles occurs almost exclusively in developing countries. 1,5 Similarly the incidence of severe pneumococcal disease including pneumonia has declined substantially in developed countries with routine immunization of young children with the conjugate vaccine. 6,7 While the burden of childhood tuberculosis (TB) is difficult to quantify, estimates are that it accounts for 15 to 20% of the TB caseload in developing countries, where the major global TB burden exists. 8 Thirdly, the paediatric HIV epidemic is now largely confined to developing countries especially those in sub-Saharan Africa, where almost 2 million HIV-infected children live. 9 Prenatal screening and effective preventative perinatal interventions have virtually eliminated pediatric HIV in developed countries. The impact of the HIV epidemic on childhood respiratory illness has been compounded by poor access and unavailability of preventative strategies and limited availability of highly active antiretroviral therapy (HAART) in developing countries. As a result, HIV-associated lung disease is a major cause of childhood morbidity, hospitalisation and mortality in sub-Saharan Africa with 90% of HIV-infected children developing a respiratory illness during the course of their HIV disease. 10 Fourthly, socio-economic factors including nutrition impact on child lung health, influencing the epidemiology and severity of illness. Co-morbid malnutrition occurs in almost half of all children dying from pneumonia. 1 Fifthly, environmental determinants of child lung health may play an important role in developing countries. For example overcrowded living conditions, exposure to biomass fuel or passive smoke exposure may be risk factors that are more prevalent in developing country settings. 11 Finally, lack of attention to the social determinants of child lung health and global inequities with large differences in access, affordability and quality of healthcare for children in developing and developed countries are important factors.